Drug prices may drop as FG implements zero VAT, duties - Newstrends
Connect with us

Health

Drug prices may drop as FG implements zero VAT, duties

Published

on

Drug prices may drop as FG implements zero VAT, duties

Experts say prices of drugs are likely to drop following the implementation of the federal government’s executive order on zero VAT and excise duties on pharmaceutical products and medical devices.

The Nigeria Customs Service yesterday said it had commenced the implementation of Value Added Tax (VAT) and import duty exemption on raw materials essential for the production of pharmaceutical products.

The National Public Relations Officer of the Nigerian Customs Service (NCS), Assistant Comptroller of Customs, Abdullahi Maiwada, in a statement on Wednesday, said the decision was in line with the presidential order to boost local production of healthcare products

President Bola Tinubu had, in June last year, signed the Executive Order to increase local production of pharmaceutical, diagnostics and medical devices.

The NCS’ spokesman said: “Critical raw materials essential for the production of pharmaceutical products will be exempted from import duty and Value Added Tax (VAT) for a period of two years.”

The statement added that the exemption covers Active Pharmaceutical Ingredients (APIs), excipients and other vital raw materials required for manufacturing essential medicines, Long-Lasting Insecticidal Nets (LLINs), Rapid Diagnostic Kits, reagents and packaging materials.

READ ALSO:

Maiwada said to ensure that these fiscal incentives are fully utilised, eligibility is limited to manufacturers of pharmaceutical products recognised by the Federal Ministry of Health and Social Welfare, provided they possess a valid Tax Identification Number (TIN).

Experts speak

Experts said the implementation of the Executive Order would address the skyrocketing cost of medicines.

A former National Secretary of the Pharmaceutical Society of Nigeria (PSN), Pharm. Iyiola Gbolagade, in a chat with our correspondent, described the implementation of the Executive Order as commendable, saying it would lead to reduction of prices some locally manufactured medicines like antibiotics and antimalarial drugs.

A former chairman of the Association of Community Pharmacists of Nigeria (ACPN) FCT chapter, Pharmacist Eneojo Made, said the implementation of Zero VAT and exercise duties on Active Pharmaceutical Ingredients (APIs), which are used to produce medicines, would boost the production of essential medicines for various categories of diseases thereby enhancing availability and access to them in the country.

A former National Publicity Secretary of the Association of Community Pharmacists of Nigeria (ACPN), Kenneth Edeh Ujah, said, “When the cost of production of medicines at various stages is lower, of course, it is going to have that direct impact on the eventual cost of the medicine when people visit the pharmacy to buy their drugs.”

Also, Prof Cyril Odianose Usifoh, the immediate past president, Pharmaceutical Society of Nigeria (PSN), said the potential for success in the order was boosted because specified items include Active Pharmaceutical Ingredients (APIs), excipients, essential raw materials required for manufacturing of crucial products, including drugs, long lasting insecticidal bed nets, rapid diagnostic kits and others.

The Federal Ministry of Health and Social Welfare had, in a statement, said the Executive Order is a significant milestone, as it opens the door for local pharmaceutical and medical device manufacturers to begin fully benefiting from the relief measures outlined by President Bola Ahmed Tinubu in the Executive Order

 

Drug prices may drop as FG implements zero VAT, duties

Loading

Health

Global Condom Prices to Rise by 30% as Iran Conflict Disrupts Supply Chains

Published

on

Condom

Global Condom Prices to Rise by 30% as Iran Conflict Disrupts Supply Chains

Global condom prices are expected to increase by up to 30% following severe disruptions in international supply chains linked to the ongoing Iran conflict, according to Malaysia-based Karex Berhad, the world’s largest condom manufacturer.

The company, which produces over five billion condoms annually for major global brands including Durex and Trojan, said rising production costs and logistics challenges have made a price hike unavoidable.

Karex also supplies condoms to public health systems such as the UK’s National Health Service (NHS) and supports United Nations-backed reproductive health programmes, making the disruption a major concern for global health supply chains.

According to Karex Chief Executive Officer Goh Miah Kiat, the Iran conflict has triggered a sharp increase in the cost of key raw materials used in condom production, including synthetic rubber, nitrile, silicone oil, and aluminium foil.

He explained that these materials are closely linked to petrochemical markets, which have been affected by rising global oil prices and instability in key shipping routes disrupted by the conflict.

READ ALSO:

“The situation is fragile and costs are rising across the board. We have no choice but to pass these increases on to customers,” he said.

The company also reported major disruptions in global logistics, with shipping times to Europe and the United States now extending to nearly two months—about twice the normal delivery period. This has caused distributors to experience shrinking inventories and has forced many buyers to place bulk advance orders, further tightening global supply.

Karex said demand for condoms has also increased as governments and distributors rush to secure stock amid uncertainty in global freight movements. The company warned that developing countries are particularly vulnerable due to limited reserves and slower replenishment systems, raising concerns about access to essential reproductive health supplies.

Industry analysts say the disruption affecting global condom supply chains reflects a broader impact on medical and protective goods, including surgical gloves and other healthcare products that rely on similar petrochemical inputs.

Despite the challenges, Karex said it currently has sufficient stock to meet short-term demand and is working to expand production capacity to stabilise global supply. The company also reaffirmed its commitment to supporting public health programmes and international aid partners while navigating ongoing market instability.

Global Condom Prices to Rise by 30% as Iran Conflict Disrupts Supply Chains

Loading

Continue Reading

Health

NAFDAC Launches Special Task Force in Kano to Combat Fake Drugs

Published

on

NAFDAC DG, Prof. Mojisola Adeyeye
NAFDAC DG, Prof. Mojisola Adeyeye

NAFDAC Launches Special Task Force in Kano to Combat Fake Drugs

The National Agency for Food and Drug Administration and Control (NAFDAC) has stepped up its nationwide crackdown on fake drugs in Nigeria with the inauguration of a seven-member task force in Kano to tackle the circulation of counterfeit medicines and unwholesome food products.

Speaking at the inauguration, NAFDAC Director-General, Mojisola Adeyeye, described the initiative as a strategic intervention aimed at strengthening enforcement and safeguarding public health. Represented by the agency’s North-West Zonal Director, Fraden Nantim-Mullah, she said the task force would operate under the Investigation and Enforcement Directorate as a federal operational arm.

Adeyeye warned that the proliferation of counterfeit drugs and substandard food products poses serious health risks, contributes to treatment failure, fuels antimicrobial resistance, and undermines confidence in Nigeria’s healthcare system.

“Kano’s status as a major commercial hub makes it highly vulnerable to the manufacture, importation, and distribution of falsified products across local and regional markets,” she said, noting that intelligence reports have continued to link the state to major supply routes for illicit pharmaceuticals in West Africa.

The Director-General explained that the task force would focus on intelligence gathering, surveillance, coordinated enforcement operations, seizure of illegal products, arrest and prosecution of offenders, as well as public sensitisation campaigns to curb the spread of fake products.

READ ALSO:

The move aligns with NAFDAC’s broader strategy to eliminate open drug markets and tighten regulatory oversight across Nigeria, particularly in high-risk zones. In recent years, the agency has intensified raids on major drug distribution centres and partnered with security agencies to dismantle networks dealing in falsified medicines.

Also speaking, the Secretary to the Kano State Government, Umar Ibrahim, said the task force was necessary to address the rising incidence of drug abuse in Nigeria and the widespread availability of counterfeit products in the state.

He noted that drug addiction remains a major social challenge, especially among youths—who make up over 70 per cent of Kano’s population—warning that the easy access to fake and unregulated substances continues to worsen the crisis.

“Recent cases of families seeking rehabilitation for their children highlight the urgent need to disrupt the supply chains of fake drugs and unsafe products,” he said.

Ibrahim called for stronger collaboration between federal and state authorities, while cautioning against interference from vested interests that could undermine enforcement efforts.

In his remarks, the task force Chairman, Kamilu Mudi-Salisu, pledged the committee’s commitment to eliminating fake drugs and unsafe food products from circulation.

He stated that the team is empowered to conduct raids, seal premises, seize illegal products, and prosecute offenders in line with existing laws. He also urged the public to support the initiative by reporting suspicious activities within their communities.

The committee comprises key regulatory and health officials, with Mudi-Salisu serving as chairman and Kasim Ibrahim acting as secretary.

Public health experts say the establishment of the Kano task force could significantly disrupt illicit supply chains if effectively implemented, particularly given the state’s strategic role in regional trade. However, they stress that sustained enforcement, community engagement, and stricter border controls will be critical to achieving long-term success.

The latest action underscores NAFDAC’s renewed commitment to protecting consumers and restoring confidence in regulated products across Nigeria, as authorities intensify efforts to curb the spread of counterfeit medicines and safeguard public health.

NAFDAC Launches Special Task Force in Kano to Combat Fake Drugs

Loading

Continue Reading

Health

Nigeria Records New COVID-19 Case in Cross River

Published

on

COVID-19 NCDC

Nigeria Records New COVID-19 Case in Cross River

The Government of Cross River State has confirmed a new COVID-19 case, triggering immediate activation of emergency health protocols, surveillance operations, and contact tracing measures across affected areas of the state.

The announcement was made in Calabar by the State Commissioner for Health, Dr Henry Ayuk, who disclosed that the case involves a 53-year-old Chinese expatriate working with Lafarge in Akamkpa Local Government Area.

According to him, the patient arrived in Nigeria on March 17, 2026, and later developed symptoms while in Cross River. He was first treated at a government health facility before being referred to the University of Calabar Teaching Hospital, where samples were taken and tested in line with established COVID-19 testing protocols. The results confirmed the presence of the virus.

Health authorities, however, assured residents that the patient is currently stable and responding to treatment, urging the public not to panic.

The commissioner explained that the state government deliberately followed due process before making the announcement public to ensure accuracy and prevent misinformation. He added that the health system in Cross River has been strengthened to handle infectious disease outbreaks and maintain effective surveillance.

READ ALSO:

The State Epidemiologist, Dr Inyang Ekpenyong, confirmed that the State Emergency Response Unit (SERU) has been activated immediately following the confirmation of the case. She said rapid response teams have been deployed to Akamkpa Local Government Area to support containment efforts.

She further disclosed that health officials have begun contact tracing and line listing of individuals who may have been exposed to the patient, particularly those he came into contact with during his movement within the state.

Ekpenyong noted that the last confirmed COVID-19 case in Cross River was recorded in 2022, making the current situation a renewed focus for public health surveillance. She added that investigations are ongoing to determine whether the infection was contracted locally or imported.

According to preliminary assessments, the patient developed symptoms on April 10, 2026—more than two weeks after arriving in Nigeria. Health experts say this falls outside the typical 2–14 day COVID-19 incubation period, raising questions about possible local transmission.

The World Health Organization (WHO) representative in Cross River, Dr Yewande Olatunde, has also urged continued vigilance, stressing that COVID-19 remains a global public health concern despite reduced emergency classification.

She advised residents to maintain preventive practices such as proper hygiene, early reporting of symptoms, and adherence to public health guidance to reduce the risk of spread.

State health authorities emphasized that there is currently no cause for alarm, noting that containment systems, surveillance teams, and emergency response structures are fully active to prevent any potential outbreak.

Officials reaffirmed their commitment to ensuring that any suspected case of COVID-19 in Nigeria is swiftly detected, isolated, and managed to protect public health.

Nigeria Records New COVID-19 Case in Cross River

Loading

Continue Reading
HostArmada Affordable Cloud SSD Shared Hosting
HostArmada - Affordable Cloud SSD Web Hosting

Trending